Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
about
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesInfluenza and Memory T Cells: How to Awake the ForceCell culture-based influenza vaccines: A necessary and indispensable investment for the futureMucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbitsSublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in miceAre we ready for pandemic influenza H5N1?Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infectionDistinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Development of stable influenza vaccine powder formulations: challenges and possibilitiesIncorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challengeSafety, immunogenicity and infectivity of new live attenuated influenza vaccines.Designing vaccines for pandemic influenza.Influenza immunology evaluation and correlates of protection: a focus on vaccines.Flexible label-free quantitative assay for antibodies to influenza virus hemagglutininsA reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.Microneedle and mucosal delivery of influenza vaccines.Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.Cross-protective immune responses elicited by live attenuated influenza vaccinesA post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India.Influence of prior influenza vaccination on antibody and B-cell responses.Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesLactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.Systems biology of vaccination for seasonal influenza in humans.Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge.Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Nanoparticles as carriers for nasal vaccine delivery.Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults.Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
P2860
Q24545856-FAF4827F-149F-4479-B55F-2278B553B1E6Q26783844-EFC0488B-0C39-48AE-9C0D-430E06AE1870Q28070255-AC62FC54-1B64-4F6A-AA1B-4AFA97EAE009Q28084739-D819C886-E186-49EF-968F-EC8D7EF06F47Q28476839-3F6DE8B6-B68C-4000-8E54-9FF9F9719227Q28727930-7C2AFE2E-DE5C-4E9F-A5F3-C26634D74DBEQ30233047-1E6C4FED-0527-402D-B30F-F60234E45FB3Q30366832-613BD59A-DA0E-4226-B2AB-5EF38E826FD1Q30368005-357FF04F-DC45-42E7-ADF9-FD5AF35BA68BQ30368221-BA8342FE-0A1E-4DEB-8E14-90B05179B35BQ30376482-C78FA237-03E7-42EC-B5BC-E6B2B8539C6AQ30378132-C4465B5E-50C9-44D8-851A-FA3FC0D71CAFQ30380889-96D80FC8-B177-4C07-A30F-FCB30D329072Q30385397-52CB48EA-69FF-4436-8D62-5ACB4FA85E54Q30391853-8E94A66F-79A2-4E3C-B83A-96E2334BAC69Q30402334-BC653090-9048-4FCC-A8F5-80AAED56B17EQ30414282-529D85DF-FF14-468F-BE7F-E22F416C9EE4Q30418015-3F9BC31C-5119-4CD2-8005-3FB437E0466CQ30419702-5B7ABF76-BA97-4D05-97A8-43DEB0DB2708Q30426540-0F308A81-AA36-4ADF-9DCA-0478EA059595Q30427619-A1535CC4-35E7-4AFD-A56C-2DEBB3574F4FQ33361605-2F5C360D-20DD-4F99-AC63-250C9009110CQ33665793-91D58A38-95CB-4DA2-8EA8-EC8AA58BFAB0Q33779792-3CC289D5-C443-43CB-86CB-0E9A73049012Q34354440-A2A9C27A-594C-47C4-805F-9D34B72A76AAQ34768241-D487278D-412D-4111-A21D-6957F7E2AA62Q35118722-CDA715DD-1FAD-4427-BFD7-85A9AE3F598AQ35142923-387C5EE7-8E87-404C-B6E8-8E8954397356Q35149731-14BF5E5E-30B0-4471-BE2A-202B8A7EED6DQ35283578-486057BB-BD66-4720-AD6B-B0BF0C05294CQ35629114-C0FC98F2-167A-4F54-970E-848CC6C0DC60Q35634295-AF50702C-F67D-4EB4-89EA-40E996ADBADCQ35826733-E44DF7E6-ED8F-47F7-858E-68C589256932Q36075789-618D25B5-D1CF-4A83-9CC0-B1F1BF3AD448Q36124952-E5C04803-C689-4AF1-92A8-12ED01C6A5D4Q36208109-DC8C6FE7-24E4-47EA-A993-33DB7BABEF79Q36276683-85749DE4-0B8D-4820-9A6D-3DE1F8C0E168Q36343776-E65BE71F-C3E7-4299-BF64-212F8B39CF7FQ36347381-082B3DA7-A99D-4274-88E6-97049D7FD0D5Q36482772-6C0994C9-0898-4599-80B9-5467B5BA053B
P2860
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@en
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@nl
type
label
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@en
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@nl
prefLabel
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@en
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@nl
P2093
P1433
P1476
Cold-adapted live influenza va ...... ine efficacy. A meta-analysis.
@en
P2093
Osterhaus AD
Palache AM
de Jong JC
P304
P356
10.1016/S0264-410X(01)00471-6
P407
P577
2002-01-01T00:00:00Z